Midatech Pharma PLC (MTP.OQ)
20 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|72||Non-Executive Chairman of the Board|
|Chief Executive Officer, Director|
|45||Finance Director, Director|
|2014||Chief Operating Officer and Chief Medical Officer|
|Chief Scientific Officer|
- BRIEF-Midatech Gets Orphan Drug Designation For Mtd119
- BRIEF-Midatech Pharma Says Approval Of Investigational New Drug Application From US FDA To Conduct Study Of MTX110
- BRIEF-Midatech Pharma Enters Into Four-Year Senior Secured Loan Agreement With Midcap Financial Of Up To $15 Mln
- BRIEF-Midatech Pharma U.S. Initiates Gelclair Phase IV Trial To Study Oral Mucositis In Stem Cell Transplant Patients